Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Device Briefing Tool and Surgical Safety Checklist Implementation

22 de noviembre de 2021 actualizado por: James Etheridge

Safe Introduction of a New Surgical Device With the Device Briefing Tool and Surgical Safety Checklist in Singapore

The investigators aim to implement a quality improvement initiative using the device briefing tool (DBT) and the Safe Surgery Checklist (SSC) and to evaluate its effect on patient safety measures and on safety culture with the introduction of a new surgical device in Singapore hospitals. Within eligible hospitals, J&J and Ariadne Labs staff will train local implementation teams to, in turn, train operating room teams to use the DBT and SSC. Project-specific outcomes will be measured by neutral observers and via survey data. Throughout the quality improvement initiative, hospitals will receive ongoing training and coaching on their interventions and feedback on their outcomes.

Descripción general del estudio

Descripción detallada

Design of Quality Improvement Initiative Using a prospective observational implementation design, surgical teams will be assigned to 1 of 2 groups. Group I will receive the complete intervention, which includes implementation of the DBT from the start, and then the DBT and SSC package.

Group II does not receive the DBT alone; these teams continue with their usual care, and then receive the DBT and SSC package.

Device-related interruptions, non-technical skills of surgical teams, and Culture of Safety Survey will be measured pre- and post-implementation of the SSC and DBT interventions, with specific timing depended on group allocation. OR teams at each hospital will be observed longitudinally to assess the effects of the DBT and SSC interventions.

Target Population for the Quality Improvement Initiative Participants will be members of the OR team at each participating hospital. These members include practicing surgeons, anesthesiologists, OR nurses, and OR staff. Hospitals will be participating institutions of SingHealth and NUHS hospital clusters. J&J device sales representatives ("reps") will serve as key trainers during the multidisciplinary trainings to use the DBT during an operation. A separate implementation team will be trained by Ariadne Labs to execute the SSC at each eligible hospital. Hospital leadership will be key stakeholders to engage at each hospital in order to implement the DBT, team training, and SSC program.

Interventions Device Briefing Tool: a 4-item mini-checklist focused on raising OR team awareness to the nuances of a new surgical device.

Trained J&J sales reps will be responsible for training OR teams to use the DBT with the new surgical device. Ariadne Labs will provide initial training to the J&J reps and be available for ongoing training support.

Safe Surgery Checklist: Developed with the World Health Organization, the SSC is a 19-item checklist consisting of verbal confirmation by surgical teams of the completion of the basic steps for ensuring the safe delivery of anesthesia, prophylaxis against infection, effective teamwork, among other essential practices in surgery. As described elsewhere in greater detail, it is used at 3 critical junctures of care: before anesthesia is administered, immediately before incision is made, and before the patient is taken out of the operating room. A successful implementation of the SSC is a labor-intensive iterative process that includes 4 phases: prepare, own, expand, and improve.

Ariadne Labs will provide the specialists needed to implement the SSC and to support local hospitals' implementation teams. Please refer to the SSC Implementation Guide for process details in the Supplemental Materials.

Outcomes to Study Device-related interruptions: Any interruption in the surgical team's workflow as the result of the use of the study device.

Non-technical skills: Evaluation of OR team performance for non-technical skills (situation awareness, decision-making, cooperation and teamwork, and leadership), using the NOTECHS assessment, a validated rating system for intraoperative OR team behavior.

Perception of safety, i.e. "safety culture": The perception of safety among members of the OR team will be measured using the Culture of Safety Survey.

Site readiness assessment: We will evaluate the readiness capacity of institutions to implement the DBT/SSC intervention using the Readiness Assessment Tool.

Goal: Determine if the pre-intervention Readiness Assessment Tool is predictive (R2 > 0.7) of implementation success as gauged by the post-intervention Implementation Survey.

Feasibility of scale: The scale of this project will be measured by the number of personnel trained, the number of hospitals at which the DBT, team training, and SSC intervention is implemented, and adherence rates to the intervention.

Tipo de estudio

De observación

Inscripción (Actual)

294

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Singapore, Singapur
        • Singapore General Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

All surgical teams operating in participating SingHealth hospitals will be eligible. Surgical teams include surgeons, anesthetists, nurses, and (in some cases) ancillary providers. The patient is not included as a member of the surgical team. Patients are not being evaluated as part of this study.

Descripción

Inclusion Criteria:

  • Surgical teams in SingHealth hospitals

Exclusion Criteria:

  • Refusal by any team member to participate

Note - there are NO specific age criteria, since the unit of analysis is the surgical team rather than the patient. It is highly unlikely that any surgical team member would be less than 18 years of age or greater than 89 years of age, but there are no explicit age-based exclusions.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Device Briefing Tool Implementation
Surgical departments which receive training on use of the Device Briefing Tool
A 4-item supplement to the WHO Surgical Safety Checklist designed to improve teamwork and communication around new/complex surgical devices
Reimplementation of the WHO Surgical Safety Checklist to improve adherence and utility of the checklist
Comparator
Surgical departments that do not receive training on use of the Device Briefing Tool
Reimplementation of the WHO Surgical Safety Checklist to improve adherence and utility of the checklist

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Oxford NOTECHS scale
Periodo de tiempo: Change in NOTECHS scores will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
Measure of non-technical skills of surgical teams assessed by neutral observers. Scored 12-48 with higher scores indicating better non-technical skills.
Change in NOTECHS scores will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Device-related interruptions (DRIs)
Periodo de tiempo: Change in DRIs will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
The number of times surgical teams must cease activity due to a problem with a surgical device
Change in DRIs will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
Culture of safety
Periodo de tiempo: Change in safety culture from baseline will be assessed 2-months post-SSC
Safety culture, as measured by division-wide Hospital Survey on Patient Safety Culture (HSOPS) survey. HSOPS is scored from 0 to 100% with higher scores indicating better safety culture.
Change in safety culture from baseline will be assessed 2-months post-SSC

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Joaquim Havens, MD, Ariadne Labs

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de noviembre de 2019

Finalización primaria (Actual)

30 de junio de 2021

Finalización del estudio (Actual)

30 de junio de 2021

Fechas de registro del estudio

Enviado por primera vez

18 de octubre de 2021

Primero enviado que cumplió con los criterios de control de calidad

5 de noviembre de 2021

Publicado por primera vez (Actual)

17 de noviembre de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

24 de noviembre de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

22 de noviembre de 2021

Última verificación

1 de noviembre de 2021

Más información

Términos relacionados con este estudio

Palabras clave

Otros números de identificación del estudio

  • IRB19-0389

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Device Briefing Tool

3
Suscribir